Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing outcomes of knee replacement using Multigen Plus H and AMF TT Cones

Official title: A Prospective, Post-marketing Study Evaluating Clinical and Radiographic Early Outcomes of Revision Total Knee Arthroplasty With Multigen Plus H Alone or Involving AMF TT Cones.

Run by Limacorporate S.p.a · NCT04884542 · Data updated 2026-11-12

This study is testing how well a specific knee replacement system works for people who need a revision surgery and what their experiences are after the procedure.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment43 (estimated)
SponsorLimacorporate S.p.a
Industry-sponsored
Locations2 sites (Ghent and 1 other locations)
StatusRecruiting
StartedJanuary 19, 2022
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedMarch 10, 2025
Trial IDNCT04884542 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are scheduled for a Total Knee Arthroplasty using the Multigen Plus H system.

Probably not a fit

Patients under 18 years old or those with contraindications for the Multigen Plus H system or AMF TT Cones will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the clinical, patient-reported, and radiographic outcomes following revision Total Knee Arthroplasty using the Multigen Plus H system and AMF TT Cones. Participants will be individuals who have already been determined to require this specific knee replacement procedure. The study will gather data on various outcomes to better understand the effectiveness and safety of these interventions in a real-world clinical setting.

Why it matters

Potential benefit: If successful, this study could improve the understanding of knee replacement outcomes, leading to enhanced patient care and surgical techniques.

How similar studies have gone: While this specific approach may not have been extensively tested, similar studies evaluating knee arthroplasty outcomes have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female
* Age ≥ 18 years old
* Given written informed consent approved by the reference Ethics Committee (EC)
* Subjects in whom a decision has already been made to perform a Total Knee Arthroplasty with the Multigen Plus H system as per Indication For Use. The decision to implant a Multigen Plus H system, alone or involving the AMF TT cones, must be taken prior to, and independently from, the decision to enrol the subject. This decision should be made in accordance with routine clinical practice at the study site concerned.
* Subject is able to comply with the protocol

Exclusion Criteria:

* Age \< 18 years old
* Subjects with any Multigen Plus system contraindication for use, or any AMF TT cones contraindication for use when used in combination with the Multigen Plus H, as reported in the current Instruction For Use.
* Any clinically significant pathology based on the medical history or any medical intervention that the Investigator feels may affect the study evaluation
* Female subjects who are pregnant, nursing, or planning a pregnancy
* Previous knee replacement on the contralateral side within the last year and whose outcome is achieving an KSS \< 70 points.

Where it's running

  • AZ Jan Palfijn Gent
    Ghent, Belgium
    Recruiting
  • Nemocnica Bory - Penta Hospital
    Bratislava, Slovakia
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.